| 中文名 | 盐酸瑞伐拉赞 |
|---|---|
| 英文名 | Revaprazan Hydrochloride |
| 英文别名 |
T66 CNT&J B1 C- DT6N CNJ BMR DF& E1 F1 &&HCl
N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine hydrochloride (1:1) 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine, monohydrochloride N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine hydrochloride Revanex 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, monohydrochloride Revaprazan HCL 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1) YH1885 |
| 描述 | Revaprazan hydrochloride 是一种新型酸泵拮抗剂 (APA)。 Revaprazan hydrochloride 可降低 COX-2 的表达,并在幽门螺杆菌感染中具有显着的抗炎作用。 |
|---|---|
| 相关类别 | |
| 靶点 |
Acid pump; COX-2[1] |
| 参考文献 |
| 熔点 | 205-208° |
|---|---|
| 分子式 | C22H24ClFN4 |
| 分子量 | 398.904 |
| 精确质量 | 398.167358 |
| PSA | 41.05000 |
| LogP | 6.03980 |
| 储存条件 | 2-8°C |